Tableaux de Dose  ›  ACE-031
Growth Factor

ACE-031 Guide & Tableau de Dose

A soluble activin receptor studied for muscle mass.

Voiesubcutaneous
ACE-031 — Tableau de dose
Chaque ligne citée
ObjectifDoseFréquenceDuréePreuveSource
Single ascending dose safety/PK/PD in healthy postmenopausal women 0.02–3 mg single dose per trial Clinical PMID 23169607
Muscle mass increase (statistically significant lean mass and thigh volume) in healthy postmenopausal women 3 mg single dose per trial Clinical PMID 23169607
Safety/PD evaluation in ambulatory boys with Duchenne muscular dystrophy 0.02–3 mg 1x/2-4 weeks per trial Clinical PMID 27462804
Skeletal muscle growth (preclinical mouse model) 10 mg per trial protocol 28 days Preclinical PMID 20466801
Suboccipital muscle hyperplasia model / intracranial pressure study in rats 10 mg per trial protocol 16 weeks Preclinical PMID 36054096
Black market product detection study in rats 10 mg single dose per trial Preclinical PMID 40312924
À des fins de recherche et d'éducation uniquement. Pas un avis médical.

ACE-031 FAQ

What is the typical ACE-031 dosage?
In research, ACE-031 has been studied at 0.02–3 mg single dose for Single ascending dose safety/PK/PD in healthy postmenopausal women (per trial). See the chart above for every studied protocol, each cited.
How do you reconstitute ACE-031?
Mix the lyophilized ACE-031 with bacteriostatic water, then use the concentration to find your draw volume. The calculator on this page does the math for you.
Is ACE-031 dosing backed by research?
Yes — every dose on this chart maps to a peer-reviewed source. Figures we cannot anchor to a study are left out. ACE-031 is a research compound for laboratory use only.